NCT00006449已完成4 期
Post-Treatment Effects of Naltrexone
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 160
- 试验地点
- 2
研究概览
简要总结
The aims of this protocol are to compare 3 and 6 months of naltrexone treatment coupled with two psychotherapies that differ in scope and intensity. The effect of these treatments will be assessed with patients who differ in their psychosocial need and resources at their disposal, and in their level of cravings for alcohol.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meets current diagnosis of alcohol dependence and have been abstinent for a minimum of 3 and maximum of 21 days prior to treatment
- •Must be able to participate in an 18-month outpatient study, and live within a one hour or less commute to treatment facility.
- •Must be fluent in English.
- •Women of childbearing potential must have a negative pregnancy test.
排除标准
- •Severe hepatic disease or a liver function test greater than 4 times normal.
- •Opiate use in the last 14 days or a history of opioid dependence in the past year.
- •Pregnant or lactating females who are not using a reliable method of birth control.
- •Inability to follow medication instructions and safety precautions.
- •Comorbid substance dependence diagnosis in the past 6-months, excluding nicotine or marijuana dependence.
- •Use of medications intended to decrease drinking.
- •Meets criteria for bipolar disorder, schizophrenia, bulimia/anorexia, dementia, major depression.
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Analyse de l’effet thérapeutique à trois mois des infiltrations du nerf pudendal dans les névralgies pudendales par syndrome canalaire. - INFILTHERAEUCTR2008-003914-87-FRCHU de Nantes
进行中（未招募）
1 期
Evaluación del efecto de 6 meses de tratamiento con V0191 sobre la evolución de los síntomas en pacientes con un déficit cognitivo leve. Estudio multicéntrico, de asignación aleatoria, doble ciego, en grupos paralelos controlado con placebo.Déficit cognitivo leveMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-ESPIERRE FABRE MEDICAMENT - IDPF210
招募中
1 期
Validation of concomitant medications affecting lamotrigine blood levelsBipolar disorder, epilepsyJPRN-jRCT1061220093Ishizawa Keisuke40
进行中（未招募）
1 期
Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole alone in non- or mildly- immunocompromised patients with Chronic Pulmonary Aspergillosis: a prospective, randomized, single blind study, (single aspergilloma excluded).MedDRA version: 20.1 Level: LLT Classification code 10022881 Term: Invasive bronchopulmonary aspergillosis System Organ Class: 100000004862EUCTR2018-000972-14-FRCHU DE POITIERS224
已完成
3 期
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsDeep Venous ThrombosisNCT00311090Sanofi757